Citius Oncology (CTOR) Finished Goods (2024 - 2026)

Citius Oncology's Finished Goods history runs 3 years deep, the most recent figure standing at $15.7 million for Q1 2026.

• In Q1 2026, Finished Goods changed N/A year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $15.7 million (changed N/A YoY), while the FY2025 annual figure was $10.6 million, up 72.42% from the prior year.
• Finished Goods was $15.7 million for Q1 2026 at Citius Oncology, roughly flat from $15.7 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $15.7 million in Q1 2026 to a low of $6.1 million in Q3 2024.
• Historically, Finished Goods has averaged $12.0 million across 3 years, with a median of $13.1 million in 2025.
• Biggest YoY gain for Finished Goods was 72.42% in 2025; the steepest drop was 72.42% in 2025.
• A 3-year view of Finished Goods shows it stood at $6.1 million in 2024, then surged by 155.71% to $15.7 million in 2025, then gained by 0.13% to $15.7 million in 2026.
• The last three Finished Goods figures came in at $15.7 million (Q1 2026), $15.7 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.